In 2022, Ao et al. combined NIR fluorescence imaging technology with LFIA to build a platform (Figure 9b) (labeled as Probe 20 in this article) that can simultaneously detect CEA, CYFRA21-1, and NSE for lung cancer diagnosis [65]. This evidence concerns the gene CEACAM5 and lung cancer.